Antibodies, Anti-Idiotypic
"Antibodies, Anti-Idiotypic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies which react with the individual structural determinants (idiotopes) on the variable region of other antibodies.
| Descriptor ID |
D000888
|
| MeSH Number(s) |
D12.776.124.486.485.114.071 D12.776.124.790.651.114.071 D12.776.377.715.548.114.071
|
| Concept/Terms |
Antibodies, Anti-Idiotypic- Antibodies, Anti-Idiotypic
- Anti-Idiotypic Antibodies
- Antibodies, Anti Idiotypic
- Anti-Idiotype Antibodies
- Anti Idiotype Antibodies
- Antibodies, Anti-Idiotype
Anti-Antibodies- Anti-Antibodies
- Antiglobulins
- Antigamma Globulin Antibodies
- Antibodies, Antigamma Globulin
- Globulin Antibodies, Antigamma
- Anti Antibodies
- Antibodies, Anti
- Anti-gamma Globulin Antibodies
- Anti gamma Globulin Antibodies
- Antibodies, Anti-gamma Globulin
- Globulin Antibodies, Anti-gamma
|
Below are MeSH descriptors whose meaning is more general than "Antibodies, Anti-Idiotypic".
Below are MeSH descriptors whose meaning is more specific than "Antibodies, Anti-Idiotypic".
This graph shows the total number of publications written about "Antibodies, Anti-Idiotypic" by people in this website by year, and whether "Antibodies, Anti-Idiotypic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 2 | 3 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 2 | 2 |
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibodies, Anti-Idiotypic" by people in Profiles.
-
Hart JD, Lutz CT, Jennings CD, May JR, Nelson K, Jacobs S, Hoopes CW. Falsely incompatible B-cell flow cytometry crossmatch after pronase treatment: a case report. Transplant Proc. 2015 Apr; 47(3):831-3.
-
Cai Y, Pulido JS. False-positive anti-retinal antibodies as a cause of psychogenic vision loss. Ocul Immunol Inflamm. 2014 Aug; 22(4):330-2.
-
Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST, Brown RH. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat Neurosci. 2010 Nov; 13(11):1396-403.
-
Pulido JS, Pulido JE, Michet CJ, Vile RG. More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial. Retina. 2010 Jan; 30(1):1-5.
-
Posner MC, Niedzwiecki D, Venook AP, Hollis DR, Kindler HL, Martin EW, Schilsky RL, Goldberg RM, Mayer RJ. A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
-
Hoopes C. Invited commentary. Ann Thorac Surg. 2006 Sep; 82(3):1088-9.
-
Rambasek T, Kavuru MS. Omalizumab dosing via the recommended card versus use of the published formula. J Allergy Clin Immunol. 2006 Mar; 117(3):708-9.
-
Zhu X, Hart R, Chang MS, Kim JW, Lee SY, Cao YA, Mock D, Ke E, Saunders B, Alexander A, Grossoehme J, Lin KM, Yan Z, Hsueh R, Lee J, Scheuermann RH, Fruman DA, Seaman W, Subramaniam S, Sternweis P, Simon MI, Choi S. Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands. J Immunol. 2004 Dec 15; 173(12):7141-9.
-
Rambasek TE, Lang DM, Kavuru MS. Omalizumab: where does it fit into current asthma management? Cleve Clin J Med. 2004 Mar; 71(3):251-61.
-
Wang C, Khalil M, Ravetch J, Diamond B. The naive B cell repertoire predisposes to antigen-induced systemic lupus erythematosus. J Immunol. 2003 May 01; 170(9):4826-32.